Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Emerg Microbes Infect ; 13(1): 2332672, 2024 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-38517841

RESUMEN

Uruguay experienced its first Chikungunya virus outbreak in 2023, resulting in a significant burden to its healthcare system. We conducted analysis based on real-time genomic surveillance (30 novel whole genomes) to offer timely insights into recent local transmission dynamics and eco-epidemiological factors behind its emergence and spread in the country.


Asunto(s)
Virus Chikungunya , Virus Chikungunya/genética , Uruguay/epidemiología , Américas/epidemiología , Brotes de Enfermedades , Genómica
2.
Epidemiol Infect ; 148: e270, 2020 11 04.
Artículo en Inglés | MEDLINE | ID: mdl-33143799

RESUMEN

In this study, an analysis of the Chilean public health response to mitigate the spread of COVID-19 is presented. The analysis is based on the daily transmission rate (DTR). The Chilean response has been based on dynamic quarantines, which are established, lifted or prolonged based on the percentage of infected individuals in the fundamental administrative sections, called communes. This analysis is performed at a national level, at the level of the Metropolitan Region (MR) and at the commune level in the MR according to whether the commune did or did not enter quarantine between late March and mid-May of 2020. The analysis shows a certain degree of efficacy in controlling the pandemic using the dynamic quarantine strategy. However, it also shows that apparent control has only been partially achieved to date. With this policy, the control of the DTR partially falls to 4%, where it settles, and the MR is the primary vector of infection at the country level. For this reason, we can conclude that the MR has not managed to control the disease, with variable results within its own territory.


Asunto(s)
Infecciones por Coronavirus/prevención & control , Pandemias/prevención & control , Neumonía Viral/prevención & control , Cuarentena , Betacoronavirus , COVID-19 , Chile/epidemiología , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/transmisión , Humanos , Neumonía Viral/epidemiología , Neumonía Viral/transmisión , SARS-CoV-2
3.
Disaster Med Public Health Prep ; 14(4): e17-e18, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32713412

RESUMEN

Mexico has been one of the most affected countries in the world by the COVID-19 pandemic. The true impact of the pandemic has probably been underestimated, and President López Obrador, as well as the Ministry of Health, has struggled to lead the country since the beginning. While cases and deaths continue to rise, stronger leadership and unity are needed to limit the impact of COVID-19 on the health of millions of Mexicans.


Asunto(s)
COVID-19/terapia , Atención a la Salud/normas , Pandemias/prevención & control , COVID-19/epidemiología , Atención a la Salud/tendencias , Humanos , Liderazgo , México/epidemiología , Pandemias/estadística & datos numéricos
4.
Disaster Med Public Health Prep ; 13(5-6): 989-994, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31156079

RESUMEN

Outbreaks of emerging infectious disease are a constant threat. In the last 10 years, there have been outbreaks of 2009 influenza A (H1N1), Ebola virus disease, and Zika virus. Stigma associated with infectious disease can be a barrier to adopting healthy behaviors, leading to more severe health problems, ongoing disease transmission, and difficulty controlling infectious disease outbreaks. Much has been learned about infectious disease and stigma in the context of nearly 4 decades of the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome pandemic. In this paper, we define stigma, discuss its relevance to infectious disease outbreaks, including how individuals and communities can be affected. Adapting lessons learned from the rich literature on HIV-related stigma, we propose a strategy for reducing stigma during infectious disease outbreaks such as Ebola virus disease and Zika virus. The implementation of brief, practical strategies such as the ones proposed here might help reduce stigma and facilitate more effective control of emerging infectious diseases.


Asunto(s)
Brotes de Enfermedades , Estigma Social , Infecciones por VIH/complicaciones , Infecciones por VIH/psicología , Haití , Fiebre Hemorrágica Ebola/complicaciones , Fiebre Hemorrágica Ebola/psicología , Humanos , Subtipo H1N1 del Virus de la Influenza A/patogenicidad , Gripe Humana/complicaciones , Gripe Humana/psicología , Virus Zika/patogenicidad , Infección por el Virus Zika/complicaciones , Infección por el Virus Zika/psicología
5.
P R Health Sci J ; 34(2): 53-9, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26061053

RESUMEN

Within the past decade, researchers and hepatitis C specialists in Puerto Rico have highlighted the burden of hepatitis C and associated disease outcomes in the island to raise public awareness about this problem and set out a call to action to tackle prevention and control efforts, yet so far no concrete actions have taken place. The population-based studies on hepatitis C have documented that the main risk factor is the sharing of syringes and drug paraphernalia to inject drugs, that most seropositive individuals are unaware of their infection status, and that there are large knowledge deficits about the disease, its risk factors, and measures of prevention and control. The subject is further complicated by the fact that despite hepatitis C reporting is mandatory, there is no effective epidemiological surveillance system to provide the information needed for planning, implementation, monitoring, and evaluation of intervention strategies for this infection and access to medical and other existing therapies is limited. This document addresses the disparities in HC V infection and its adverse outcomes experienced among Puerto Ricans and attempts to set out strategies to address a public health response for hepatitis C at the meso and macro levels of the social-ecological model. Diverse organizations and major stakeholders are urged to mount an adequate response to hepatitis C by transforming current scientific evidence into public health actions to increase awareness, identify those who are actively infected, and link infected individuals into comprehensive care and treatment.


Asunto(s)
Hepatitis C/epidemiología , Hepatitis C/prevención & control , Humanos , Salud Pública , Puerto Rico/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA